OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Charity Commission Registration No. 286363

THE BRITISH NEUROPATHOLOGICAL SOCIETY

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST DECEMBER 2025

British Neuropathological Society- President’s Report 2025

During 2025, the British Neuropathological Society continued to advance its charitable aims through scientific meetings, education, professional support and international collaboration.

The 126th Annual Meeting of the British Neuropathological Society was held from 29 to 31 January 2025 at The View, Royal College of Surgeons of England, London. The meeting opened with a symposium on spatial transcriptomics, bringing together internationally recognised speakers (Prof Schirmer, Heidelberg, Germany; Dr Bayraktar, Cambridge, UK; Prof Duff, UCL, UK; Prof Heiland, Erlangen, Germany; Dr Watson, Oxford, UK and Prof Gerstung, DKFZ, Germany) to discuss the use of spatial and high-dimensional technologies in inflammatory disease, neurodegeneration and brain tumours. Professor David Ellison of St Jude Children’s Research Hospital, USA, delivered the Alfred Meyer Memorial Lecture on “The challenges of classifying brain tumors”. The Thursday and Friday scientific programme covered brain tumours, neurodegeneration, and a broad range of topics in experimental and diagnostic neuropathology. It included platform presentations, flash talks and poster discussions, as well as the Society’s Professional Affairs and Business Meetings. The final day featured a Clinical Update Session on epilepsy pathology, followed by case reports and the Diagnostic Slide Session, which incorporated the External Quality Assurance Scheme. The meeting concluded with the announcement of prizes.

The Society continued to support networking and engagement among the next generation of neuropathologists and neuroscientists. A BNS Next Generation Social was held at the Gordon Museum of Pathology immediately before the Annual Meeting. The Society contributed a donation towards the Museum’s upkeep.

Continuing education through meetings, symposia and training remains central to the Society’s charitable purpose. Its residential Summer School is held every two years at the Royal Agricultural College in Cirencester. The 2025 Summer School, “Brain Tumour Diagnostics: Decoding Principles and Controversies”, examined the growing integration of histopathology, molecular testing and emerging technologies in diagnostic neuropathology. The programme explored novel tumour entities, artificial intelligence and digital pathology, while interactive case-based sessions allowed participants to apply these principles in practice.

The trustees remain committed to broadening participation in meetings and forums relevant to clinical neuropathology and applied neurobiology, particularly for trainees, early-career scientists and others at an early stage of their careers. The Society continued its bursary and small-grant schemes to support research, education and attendance at scientific meetings. It also purchased four places for clinical trainees on Euro-CNS training courses and supported other educational activities, including initiatives organised by the Royal College of Pathologists.

The Society supports the International Society of Neuropathology and Euro-CNS through annual percapita membership subscriptions, enabling BNS members to take part in their activities and educational programmes and access their publications. It has also committed substantial financial support to the European Congress of Neuropathology 2027 to be held in Edinburgh reflecting its commitment to supporting international neuropathology and showcasing UK neuropathology on the global stage.

Royalties from Neuropathology and Applied Neurobiology , published by Wiley on the Society’s behalf, remain a major source of annual income. As a charity, the BNS is governed by trustees comprising the President, Vice-President, Honorary Secretary and Treasurer. They are responsible for ensuring that the Society delivers clear charitable benefit while maintaining sustainable finances. Membership subscriptions for consultants and members holding substantive appointments were increased to reflect the rising cost of member benefits and charitable activities.

The Society continues to support diagnostic neuropathology as a GMC-recognised independent medical specialty through work on recruitment, curriculum development, training and assessment. It also funds and supports its fully digitised External Quality Assurance Scheme. High participation and continuous professional review help maintain diagnostic standards and public confidence in the national neuropathology service.

Professor Silvia Marino, MD FRCPath

THE BRITISH NEUROPATHOLOGICAL SOCIETY

LEGAL AND ADMISTRATIVE INFORMATION

Trustees Dr Silvia Marino (President) Dr Kathreena Kurian (Vice President) Dr Karl Frontzek (Treasurer) Dr Daniel Erskine (Secretary) Accountants Orcom Civvals Limited Chartered Accountants 50 Seymour Street London W1H 7JG Bankers Bank of Scotland 174 Byres Road Glasgow G12 8SW COIF Charity Funds CCLA Investment Management Ltd St Alphage House 2 Fare Street London EC2Y 5AQ Principal Address 50 Seymour Street London W1H 7JG 286363

Principal Address Charity Commission Registration Number

THE BRITISH NEUROPATHOLOGICAL SOCIETY

TRUSTEES REPORT

The Trustees present their annual report on the affairs of the Society together with the financial statements and independent examiners report for the year ended 31st December 2025.The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the charity’s trust deed, the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland published on 16 July 2014.

Legal & Administrative

The Society is registered as a charity in the United Kingdom, number 286363, and its operations are subject to the Charities Acts 1960 to 2011.

Objects

The object of the Society is to further the study of neuropathology, to promote the exchange of scientific information by means of regular meetings, lectures and demonstrations, and to provide the opportunity for discussions between neuropathologists in Britain and other countries.

The trustees consider that by meeting these objectives they will also meet the Public Benefit test applicable to all Charities.

The financial statements of the Society provide details of major activities undertaken and how the activities have been financed.

The Society has three restricted funds the objects of which are: -

Dorothy Russell and Alfred Meyer Memorial Funds

To provide scientific symposium and lectures in alternate years

NEQAS Fund

To provide quality assurance in relation to neuropathology, to improve and standardise diagnostic neuropathology.

Trustees

The Trustees are listed on page 1.

Organisation

The Society relies, and will continue to rely, on the voluntary work undertaken by the trustees, members of committees and other volunteers. The Society has no employees.

The trustees are elected by the members and, following election, serve a fixed term at the end of which they may stand for reelection if there are no other candidates. Trustees undertake their own training to ensure they achieve their fiduciary duties.

The trustees meet at the Society’s business meetings twice a year at which time strategic decisions are taken.

The trustee and committee meetings are designed to promote and concentrate the educational and scientific value of the Society's activities.

The trustees have a policy to widen representation of the members on committees.

The Society is affiliated to various European bodies but no formal responsibilities to those organisations exist. There are no related parties or subsidiaries.

THE BRITISH NEUROPATHOLOGICAL SOCIETY

TRUSTEES REPORT

Investment Powers

The trustees are permitted to make any investment that they see fit, but in view of the current financial climate consider the best arrangements for surplus funds are with the Charities Investment Fund.

Risk Management

The Trustees regularly review the charity’s activities and consider the opportunities available to the charity to enable it to meet its objectives and the risks to which it is exposed. As part of this process the trustees review the risks which the charity may face, establish systems and procedures to mitigate those risks identified and implement procedures designed to minimise any potential impact on the charity should any of those risks materialise.

The systems are designed to provide reasonable, but not absolute, assurance against material misstatement or loss.

They include regular consideration of financial results, variance from budgets, segregation of duties and the identification and management of risks.

Reserves

The Committee are conscious that in recent years the reserves of the Society have increased to a greater level than would be required to maintain activities even if funding from the journal were to reduce considerably. It is the Trustees intention that unrestricted funds should be reduced to approximately £250,000 over forthcoming years. This will be achieved by an increase number of research grants where suitable projects are proposed and increased academic, training and educational activities. It is also hoped to achieve digitalization and computerisation -online- for society meetings and EQAs, for this a training programme for some members has already begun.

Responsibilities of Trustees

Charity Law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the results of the Charity for the period, together with its assets and liabilities at the end of the period and adequately distinguish any material special trust or other restricted fund of the charity. In preparing those financial statements, the Trustees are required to:

Select suitable accounting policies and then apply them consistently;

Make judgements and estimates that are reasonable and prudent;

State whether the policies adopted are in accordance with the appropriate SORP on Accounting by Charities and the Accounting Regulations and with applicable accounting standards, subject to any material departures disclosed and explained in the financial statements; and

Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and to enable them to ensure that the financial statements comply with applicable Accounting Standards and Statements of Recommended Practice and the regulations made under s44 of the Charities Act 1993. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Dr Silvia Marino BNS President (dated)….............

THE BRITISH NEUROPATHOLOGICAL SOCIETY

INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES

I report on the accounts of the Trust for the year ended 31 December 2025, which are set out on pages 6 to 9.

Respective responsibilities of trustees and examiner

The charity’s trustees are responsible for the preparation of the accounts. The charity's trustees consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 (the Act) and that an independent examination is needed.

Basis of independent examiners’ report

My examination was carried out in accordance with the General Directions given by the Charity Commissioners. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and the seeking of explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and, consequently, I do not express an audit opinion on the view given by the accounts.

Independent examiners’ statement

In connection with my examination, no matter has come to my attention:

to prepare accounts which accord with the accounting records and to comply with the accounting  requirements of the Act

have not been met; or

to which, in my opinion, attention should be drawn in order to enable a proper understanding of  the accounts to be reached.

M Gibbons FCA Orcom Civvals Limited 50 Seymour St Chartered Accountants London W1H 7JG

8 October 2026

THE BRITISH NEUROPATHOLOGICAL SOCIETY

STATEMENT OF FINANCIAL ACTIVITIES

FOR THE YEAR ENDED 31ST DECEMBER 2025

INCOME & EXPENDITURE

Incoming resources
Subscriptions
Meeting Income
Surplus from Journal
Interest receivable
Direct charitable
Publishing Costs
Cost of meetings
3
Grants & sponsorship
4
Subscriptions
5
EQA costs
Support expenditure:
Committee expenses
6
Website design
Administrative costs
Bank Charges
Accountancy
TOTAL EXPENDITURE
NET INCOME FOR THE
Fund balances brought
FUND BALANCES
Unrestricted
Funds
£
10,137
23,824
133,124
10,148
177,233
24,150
234,310
32,315
0
0
290,774
2,747
3,600
6,521
90
6,120
19,078
309,852
(132,619)
670,402
£537,783
Restricted
Funds
£
4,127
4,127
0
0
0
4,127
51,579
£55,706
Total
2025
£
10,137
23,824
137,251
10,148
181,360
24,150
234,310
32,315
0
0
290,774
2,747
3,600
6,521
90
6,120
19,078
309,852
(128,492)
721,981
£593,489
Total
2024
£
9,671
25,668
136,324
17,389
189,052
8,890
99,932
37,450
5,535
3,047
154,854
815
4,680
200
165
2,940
8,800
163,654
42,050
696,583
£738,633

THE BRITISH NEUROPATHOLOGICAL SOCIETY

BALANCE SHEET AS AT 31ST DECEMBER 2025

2025
Note
£
CURRENT
Cash deposits
7
593,489
593,489
LESS:
Creditors
8
0
NET CURRENT
Total assets
less current
liabilities
Represented by:
Unrestricted
General Purpose
Restricted
2
Dorothy Russell
5,041
Alfred Meyer
44,098
NEQAS Fund
2,788
£
593,489
£593,489
541,562
51,927
£593,489
2024
£
727,861
727,861
5,880
5,054
48,505
-1,980
£
721,981
£721,981
670,402
51,579
£721,981

Approved by the Trustees and signed on their behalf on 22 Oct 2026

Dr Karl Frontzek Treasurer

THE BRITISH NEUROPATHOLOGICAL SOCIETY

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 31ST DECEMBER 2025

1. ACCOUNTING POLICIES

(a) These accounts reflect all funds held by the charity, which are governed by the Bye Laws, adopted on 14th July 1977 as amended on 11th January 1991 and 3rd March 2021. The funds held are utilised in accordance with the trusts under which the Trustees are empowered in the Bye Laws.

(b) The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the charity’s trust deed, the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland published on 16 July 2014.

There has been no change to the accounting policies (valuation rules and methods of accounting) since last year.

(c) The accounts have been prepared under the historical cost convention on an accruals basis and include income and expenditure as they are earned or incurred rather than as cash is received or paid, except in the case of the surplus from journal, which is accounted for when received from the publisher.

2. ANALYSIS OF RESTRICTED FUNDS

Income
Subscriptions receivable
Interest received
Expenditure
Lecture costs
Laboratory costs
Online subscription
Net Income For Year
Fund Balance Brought
FUND BALANCE
Dorothy
Russell
Memorial
Fund
Alfred
Meyer
Memorial
Fund
EQA Fund
TOTAL
£
£
£
4,127
4,127
442
3,869
641
4,952
442
3,869
4,768
9,079
0
219
6,215
6,434
0
219
6,215
0
6,434
223
(2,346)
4,768
2,645
4,818
46,444
(1,980)
49,282
5,041
44,098
2,788
51,927

SH NEUROPATHOLOGICAL SOCIETY

NOTES TO THE ACCOUNTS

YEAR ENDED 31ST DECEMBER 2025

3. MEETINGS Meeting costs

2025
£
234,310
234,310
2024
£
99,932
99,932
4. GRANTS &
Research grants &
Sponsorship
5. SUBSCRIPTIONS
Euro CNS
International Society of
6. TRUSTEES
Committee room hire
The trustees received no
remuneration during the
year (2024: nil)
7. CASH DEPOSITS
Unrestricted general
Unrestricted journal fund
Dorothy Russell Memorial
NEQAS Restricted fund
Alfred Meyer Memorial
8. CREDITORS
Creditors
2025
30,460
1,855
32,315
0
0
2,747
2,747
425,890
115,671
5,042
2,788
44,098
593,489
0
0
2024
37,450
0
37,450
5,535
5,535
815
815
568,097
110,930
4,835
1,708
42,291
727,861
5,880
5,880